Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1998
12/29/1998CA2171281C Immunomodulating compositions from bile
12/29/1998CA2129554C Recombinant antibodies specific for tnf-.alpha.
12/29/1998CA2064029C Use of mycobacterium vaccae in the prevention of aids
12/29/1998CA2045478C Xanthine compounds
12/29/1998CA1340297C Conjugation of polymer to colony stimulating factor-1
12/29/1998CA1340296C Cell growth regulatory factor
12/24/1998DE19726255A1 Beeinflussung von Cytokinen durch proteolytische Enzyme Influence of cytokines by proteolytic enzymes
12/24/1998DE19726244A1 Verwendung proteolytischer Enzyme zur Vorbeugung bzw. Behandlung der Transplantatabstoßung The use of proteolytic enzymes to prevent or treat graft rejection
12/24/1998DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists
12/24/1998CA2234418A1 Human afc1
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998058066A1 New human lysophospholipase
12/23/1998WO1998058059A1 Lag-3 splice variants
12/23/1998WO1998057993A1 Secretory immunoglobulin produced by single cells and methods for making and using same
12/23/1998WO1998057991A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057979A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998WO1998057976A1 Secreted proteins and polynucleotides encoding them
12/23/1998WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998WO1998057961A1 Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/23/1998WO1998057939A1 Crystalline roxifiban
12/23/1998WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998WO1998057661A1 Therapeutic composition and method of treatment
12/23/1998WO1998057657A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998EP0885889A2 Process for the preparation of pyrazole-3-carboxylic acids
12/23/1998EP0885611A2 Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
12/23/1998EP0885299A1 Wsx receptor and ligands
12/23/1998EP0885244A1 Peptide immunogens for vaccination against and treatment of allergy
12/23/1998EP0885229A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
12/23/1998EP0885227A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION
12/23/1998EP0885226A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production
12/23/1998EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
12/23/1998EP0885188A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
12/23/1998EP0885011A2 Vaccines
12/23/1998EP0884947A1 Dna vaccination for induction of suppressive t cell response
12/23/1998EP0728012A4 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
12/23/1998EP0473721B1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/23/1998CN1202934A Delivery of biologically active polypeptides
12/23/1998CN1202905A Parainfluenza virus glycoproteins and vaccines
12/23/1998CN1202904A Cyclopeptolides
12/23/1998CN1202894A Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases
12/23/1998CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists
12/23/1998CN1202818A Solubilisation method
12/23/1998CA2295994A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998CA2295440A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998CA2294569A1 Secreted proteins and polynucleotides encoding them
12/23/1998CA2294563A1 New human lysophospholipase
12/23/1998CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998CA2294047A1 Crystalline roxifiban
12/23/1998CA2293735A1 Lag-3 splice variants
12/23/1998CA2292912A1 Therapeutic composition and method of treatment
12/23/1998CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/22/1998US5852190 Diazepinoindoles as phosphodiesterase IV inhibitors
12/22/1998US5852186 Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof
12/22/1998US5852176 Antibodies to receptors for human interleukin-12
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852002 Treatment of conditions and disease
12/22/1998US5851984 Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
12/22/1998US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus
12/22/1998US5851806 Complementary adenoviral systems and cell lines
12/22/1998US5851801 Method of preparing polypeptide binding compositions derived from immunoglobulin variable regions
12/22/1998US5851795 Soluble CTLA4 molecules and uses thereof
12/22/1998US5851793 Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2
12/22/1998US5851756 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
12/22/1998US5851523 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
12/22/1998CA2059363C Benzo¬5,6|cyclohepta¬1,2-b|pyridine derivatives and antiallergic agents comprising same
12/20/1998CA2235441A1 Novel compounds
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998056931A1 Attenuated recombinant mycobacteria useful as immunogens or as vaccine components
12/17/1998WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response
12/17/1998WO1998056913A1 Smad6 and uses thereof
12/17/1998WO1998056909A2 Secreted proteins and polynucleotides encoding them
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056818A1 Human l105 proteins and polynucleotides encoding same
12/17/1998WO1998056816A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE
12/17/1998WO1998056783A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
12/17/1998WO1998056420A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998WO1998056418A1 Stabilized antibody formulation
12/17/1998WO1998056417A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998WO1998056416A1 Immunogenic compositions for induction of anti-tumor immunity
12/17/1998WO1998056415A1 Purified saponins as oral adjuvants
12/17/1998WO1998056414A1 Oil in water vaccine compositions
12/17/1998WO1998056413A1 Multivalent in ovo avian vaccine
12/17/1998WO1998056412A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI 26kDa POLYPEPTIDE
12/17/1998WO1998056410A1 Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence
12/17/1998WO1998056401A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998WO1998056371A1 Use of cis-6-hexadecenoic acid for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin
12/17/1998WO1998056358A1 Rapamycin formulations for oral administration
12/17/1998WO1998042708A3 Pharmaceutically active tricyclic amines
12/17/1998WO1998039034A3 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
12/17/1998WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998DE19724622A1 Verwendung von cis-6-Hexadecensäure zur Behandlung von Psoriasis, Allergien und Autoimmunerkrankungen Using cis-6-hexadecenoic acid for the treatment of psoriasis, allergies and autoimmune diseases
12/17/1998CA2301196A1 Multivalent in ovo avian vaccine
12/17/1998CA2295982A1 Human l105 proteins and polynucleotides encoding same
12/17/1998CA2295980A1 Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2293826A1 Attenuated recombinant mycobacteria useful as immunogens or as vaccine components
12/17/1998CA2293825A1 Secreted proteins and polynucleotides encoding them
12/17/1998CA2293666A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same
1 ... 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 ... 1172